AKT1 and cancer: The PI3K/Akt/mTOR signaling axis, defined by phosphatidylinositol-3 kinase (PI3K), protein kinase B (Akt), and mechanistic target of rapamycin (mTOR), is a complex pathway with several upstream regulators and downstream effectors that play a key role in cancer pathology [17].